A potent, cell-permeable inhibitor of farnesyltransferase (FTase) that is about 37-fold more active against FTase (IC50 = 21 nM in vitro) than against geranylgeranyltransferase (GGTase; IC50 = 790 nM). Very resistant to proteolysis.
A potent, cell-permeable, selective, peptidomimetic inhibitor of farnesyltransferase (FTase) that is approximately 37-fold more active against FTase (IC50 = 21 nM in vitro) than against geranylgeranyltransferase (GGTase; IC50 = 790 nM). Very resistant to proteolysis.
生物化学的/生理学的作用
Cell permeable: yes
Primary Target FTase
Product does not compete with ATP.
Reversible: no
Target IC50: 21 nM against FTase in vitro
包装
Packaged under inert gas
警告
Toxicity: Standard Handling (A)
物理的形状
Supplied as a trifluoroacetate salt.
再構成
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
その他情報
Yamaguchi, M., et al. 2004. Stroke35, 1750. Cox, A.D., et al. 1994. J. Biol. Chem.269, 19203. Garcia, A.M., et al. 1993. J. Biol. Chem. 268, 18415.
法的情報
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Serotonin neurotransmission is largely governed by the regulation of the serotonin transporter (SERT). SERT is modulated in part by cholesterol, but the role of cholesterol and lipid signaling intermediates in regulating SERT are unknown. Serotonergic neurons were treated with statins
Early embryos are vulnerable to environmental insults, such as medications taken by the mother. Due to increasing prevalence of hypercholesterolemia, more women of childbearing potential are taking cholesterol-lowering medications called statins. Previously, we showed that inhibition of the mevalonate pathway